AI in Protein Engineering Market: Global Forecast to 2031

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3.1 AI IN PROTEIN ENGINEERING MARKET OVERVIEW
3.2 AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION & COUNTRY
3.3 AI IN PROTEIN ENGINEERING MARKET: GEOGRAPHIC SNAPSHOT

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing adoption of generative AI and protein foundation models
4.2.1.2 Rising demand for next-generation biologics and engineered proteins
4.2.1.3 Increasing availability of protein sequence, structure, and experimental datasets
4.2.2 RESTRAINTS
4.2.2.1 Limited availability of high-quality experimentallyvalidated protein data
4.2.2.2 High cost and complexity of experimental validation
4.2.3 OPPORTUNITIES
4.2.3.1 Expansion of AI-designed de novo proteins
4.2.3.2 Growth of AI-enabled antibody discovery and optimization
4.2.3.3 Increasing demand for proprietary protein-engineering datasets
4.2.4 CHALLENGES
4.2.4.1 Biosecurity and biosafety concerns
4.2.4.2 Lack of standardized benchmarking across AI protein-engineering platforms
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5.1 INDUSTRY TRENDS IN GLOBAL AI IN PROTEIN ENGINEERING MARKET
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 THREAT OF NEW ENTRANTS
5.2.5 INTENSITY OF COMPETITIVE RIVALRY
5.3 MACROECONOMIC INDICATORS
5.3.1 INTRODUCTION
5.3.2 GDP TRENDS AND FORECAST
5.3.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & PRODUCT DEVELOPMENT
5.4.2 DATA INPUTS & COMPUTATIONAL INFRASTRUCTURE
5.4.3 AI MODEL & PLATFORM DEVELOPMENT
5.4.4 PLATFORM DEPLOYMENT & INTEGRATION
5.4.5 MARKETING AND SALES
5.4.6 POST-SALE SERVICES
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,BY OFFERING (2025)
5.6.2 INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,BY REGION (2025)
5.7 KEY CONFERENCES AND EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.11 IMPACT OF 2025 US TARIFF - AI IN PROTEIN ENGINEERING MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.4.1 US
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END USERS
5.11.5.1 Pharmaceutical & biotechnology companies
5.11.5.2 Academic & research institutes
5.11.5.3 Contract research organizations
5.11.5.4 Industrial biotechnology companies
5.11.5.5 Other end users

6.1 KEY EMERGING TECHNOLOGIES
6.1.1 GENERATIVE AI FOR PROTEIN DESIGN
6.1.2 PROTEIN LANGUAGE MODELS (PLMS)
6.1.3 STRUCTURE-BASED AI FOR PROTEIN ENGINEERING
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 HIGH-PERFORMANCE COMPUTING (HPC) AND CLOUD COMPUTING
6.2.2 LABORATORY AUTOMATION AND HIGH-THROUGHPUT SCREENING
6.3 ADJACENT TECHNOLOGIES
6.3.1 COMPUTATIONAL CHEMISTRY AND MOLECULAR SIMULATION
6.3.2 BIOINFORMATICS AND BIOLOGICAL DATA ANALYTICS
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
6.5.1 PATENT PUBLICATION TRENDS FOR AI IN PROTEIN ENGINEERING MARKET
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 AI-ENABLED INTELLIGENT PROTEIN DESIGN AND PREDICTION
6.6.2 AI-DRIVEN AUTOMATED PROTEIN ENGINEERING AND DESIGN-BUILD-TEST-LEARN
6.6.3 AI-ENABLED PERSONALIZED AND FUNCTION-SPECIFIC PROTEIN ENGINEERING

7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 ASIA PACIFIC
7.1.2.4 LATIN AMERICA
7.1.2.5 Middle East & Africa
7.1.3 INDUSTRY STANDARDS

8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5.1 UNMET NEEDS
8.5.2 END USER EXPECTATIONS
8.6 MARKET PROFITABILITY

9.1 INTRODUCTION
9.2 SOFTWARE/PLATFORMS
9.2.1 NICHE POINT SOLUTIONS
9.2.1.1 Specialized AI platforms expand protein engineering beyondend-to-end workflows
9.2.2 END-TO-END SOLUTIONS
9.2.2.1 Integrated AI platforms enable multi-stage protein engineering and accelerate candidate development
9.3 SERVICES
9.3.1 CONSULTING & ADVISORY SERVICES
9.3.1.1 Increasing complexity of AI adoption creates demand for protein engineering strategy and technical expertise
9.3.2 IMPLEMENTATION & INTEGRATION SERVICES
9.3.2.1 Integration complexity and data compatibility shape adoption ofAI protein engineering solutions
9.3.3 TRAINING & SUPPORT SERVICES
9.3.3.1 Specialized skills gaps and evolving AI technologies sustain demand for training & support

10.1 INTRODUCTION
10.2 MACHINE LEARNING & DEEP LEARNING
10.2.1 FOUNDATIONAL NEURAL ARCHITECTURES UNDERPIN MODERN PROTEIN ENGINEERING WORKFLOWS
10.3 PROTEIN LANGUAGE MODELS
10.3.1 EVOLUTION-SCALE SEQUENCE MODELS ENABLE PREDICTION AND GENERATION WITHOUT STRUCTURAL INPUTS
10.4 GENERATIVE AI
10.4.1 GENERATIVE MODELS MOVE ANTIBODY AND BINDER DESIGN FROM SCREENING TO PROGRAMMABLE DESIGN
10.5 STRUCTURE-BASED AI
10.5.1 ACCURATE COMPLEX PREDICTION SUPPORTS EPITOPE-SPECIFIC DESIGN AND AFFINITY ESTIMATION
10.6 OTHER TOOLS
10.6.1 ACTIVE LEARNING, BAYESIAN OPTIMIZATION, AND LAB-IN-THE-LOOP PLATFORMS COMPLEMENT CORE MODEL CLASSES

11.1 INTRODUCTION
11.2 NEXT-GENERATION BIOLOGICS
11.2.1 THERAPEUTIC PROTEIN ENGINEERING
11.2.1.1 AI-optimized antibodies and engineered proteins move into late-stage development
11.2.2 MULTISPECIFIC & BISPECIFIC PROTEIN ENGINEERING
11.2.2.1 Dual-targeting formats attract record licensing investment as engineering platforms mature
11.2.3 CYTOKINE & GROWTH FACTOR ENGINEERING
11.2.3.1 Redesigned cytokines aim to separate therapeutic benefit from systemic toxicity
11.2.4 PROTEIN BINDER ENGINEERING
11.2.4.1 De novo binder design reaches double-digit to near-complete experimental hit rates
11.2.5 OTHER NEXT-GENERATION BIOLOGICS
11.2.5.1 Antibody-drug conjugates, scaffold fusions, and novel formats broaden engineering toolkits
11.3 MOLECULAR GLUES
11.4 DATA GENERATION
11.5 ANTIBODY DISCOVERY & OPTIMIZATION
11.5.1 ANTIBODY DISCOVERY
11.5.1.1 Generative design reduces dependence on immunization and library screening
11.5.2 ANTIBODY AFFINITY OPTIMIZATION
11.5.2.1 Computational lead optimization improves potency and dosing convenience
11.5.3 ANTIBODY SPECIFICITY & CROSS-REACTIVITY OPTIMIZATION
11.5.3.1 Atomic-level design enables selective binding and controlled species cross-reactivity
11.5.4 ANTIBODY DEVELOPABILITY OPTIMIZATION
11.5.4.1 Early developability screening reduces late-stage attrition risk
11.5.5 BISPECIFIC & MULTISPECIFIC ANTIBODY ENGINEERING
11.5.5.1 Maturing formats and design platforms extend beyond oncology T-Cell engagers
11.5.6 OTHER ANTIBODY ENGINEERING
11.5.6.1 Fc modification, half-life extension, and delivery formats broaden antibody differentiation
11.6 ENZYME ENGINEERING
11.7 DE NOVO PROTEIN DESIGN
11.8 PROTEIN STABILITY & DEVELOPABILITY OPTIMIZATION
11.9 OTHER APPLICATIONS

12.1 INTRODUCTION
12.2 ANTIBODIES
12.2.1 AI-DRIVEN ANTIBODY DESIGN AND OPTIMIZATION ACCELERATE NEXT-GENERATION BIOLOGICS DEVELOPMENT
12.3 ENZYMES
12.3.1 AI-POWERED ENZYME ENGINEERING EXPANDS APPLICATIONS ACROSS INDUSTRIAL BIOCATALYSIS
12.4 CYTOKINES & GROWTH FACTORS
12.4.1 ADVANCING PRECISION ENGINEERING OF CYTOKINES AND GROWTH FACTORS
12.5 PEPTIDES
12.5.1 AI ADDRESSES COMPLEXITY IN PEPTIDE SEQUENCE DESIGN AND FUNCTIONAL OPTIMIZATION
12.6 FUSION PROTEINS
12.6.1 AI IMPROVES MULTI-DOMAIN DESIGN OF FUSION PROTEINS
12.7 MINIPROTEIN
12.7.1 DE NOVO MINIPROTEIN DESIGN OPENS NEW OPPORTUNITIES FOR PRECISION BIOLOGICS
12.8 OTHER PROTEINS
12.8.1 EMERGING PROTEIN MODALITIES CREATE NEW OPPORTUNITIES FOR AI-ENABLED ENGINEERING

13.1 INTRODUCTION
13.2 PROTEIN DISCOVERY
13.2.1 EXPANDING SEQUENCE AND STRUCTURE DATABASES ACCELERATE TARGET AND STARTING-POINT IDENTIFICATION
13.3 PROTEIN DESIGN
13.3.1 OPEN GENERATIVE MODELS MOVE DE NOVO DESIGN FROM PROOF OF CONCEPT TO BROAD EXPERIMENTAL VALIDATION
13.4 PROTEIN OPTIMIZATION
13.4.1 MACHINE LEARNING-GUIDED OPTIMIZATION IMPROVES AFFINITY, STABILITY, AND MANUFACTURABILITY ACROSS ITERATIVE CYCLES
13.5 PROTEIN CHARACTERIZATION
13.5.1 HIGHER-RESOLUTION STRUCTURAL AND BIOPHYSICAL ANALYSIS ANCHORS COMPUTATIONAL PREDICTIONS IN EXPERIMENTAL REALITY
13.6 EXPERIMENTAL VALIDATION
13.6.1 CLOUD LABS, PUBLIC COMPETITIONS, AND LAB-IN-THE-LOOP PLATFORMS SCALE WET-LAB TESTING

14.1 INTRODUCTION
14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
14.2.1 HIGH R&D INVESTMENTS AND GROWING AI INTEGRATION ACCELERATE PROTEIN ENGINEERING ADOPTION
14.3 ACADEMIC & RESEARCH INSTITUTES
14.3.1 ADVANCING PROTEIN SCIENCE THROUGH AI-ENABLED RESEARCHAND COMPUTATIONAL DESIGN
14.4 CONTRACT RESEARCH ORGANIZATIONS
14.4.1 AI HELPS CROS DIFFERENTIATE PROTEIN ENGINEERING SERVICESAND EXPAND OUTSOURCED DISCOVERY CAPABILITIES
14.5 INDUSTRIAL BIOTECHNOLOGY COMPANIES
14.5.1 AI-DRIVEN BIOCATALYST DEVELOPMENT ACCELERATESADOPTION IN INDUSTRIAL BIOTECHNOLOGY
14.6 OTHER END USERS
14.6.1 EXPANSION OF AI-ENABLED PROTEIN ENGINEERING ACROSS DIVERSE APPLICATIONS TO BOOST SEGMENT

15.1 INTRODUCTION
15.2 NORTH AMERICA
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
15.2.2 US
15.2.2.1 AI-driven protein design and strong biopharmaceuticalR&D support market growth
15.2.3 CANADA
15.2.3.1 Government support for AI innovation and biomanufacturing strengthens market growth
15.3 EUROPE
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
15.3.2 GERMANY
15.3.2.1 Strong pharmaceutical research base and AI innovationdrive protein engineering adoption
15.3.3 FRANCE
15.3.3.1 Biopharma innovation and research commercialization support market expansion
15.3.4 UK
15.3.4.1 Regulatory innovation and AI-driven drug discovery accelerate adoption
15.3.5 ITALY
15.3.5.1 Pharmaceutical manufacturing strength and research modernization create opportunities
15.3.6 SPAIN
15.3.6.1 Strong pharmaceutical R&D and biopharma ecosystem support market growth
15.3.7 REST OF EUROPE
15.4 ASIA PACIFIC
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.2 CHINA
15.4.2.1 AI-driven protein engineering and biologics innovation reshape pharmaceutical development
15.4.3 JAPAN
15.4.3.1 Demographic pressures and AI innovation drive protein engineering adoption
15.4.4 INDIA
15.4.4.1 Cost-efficient innovation and biotechnology expansion support growth
15.4.5 AUSTRALIA
15.4.5.1 Translational research ecosystem supports AI-enabled protein engineering
15.4.6 SOUTH KOREA
15.4.6.1 Biotechnology Expansion and AI investments supportprotein engineering adoption
15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
15.5.2 BRAZIL
15.5.2.1 Leading regional pharmaceutical research activity supportsmarket growth
15.5.3 MEXICO
15.5.3.1 Pharmaceutical manufacturing base and growing R&Dactivity support AI adoption
15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST & AFRICA
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
15.6.2 GCC COUNTRIES
15.6.2.1 Healthcare transformation and biotechnology investments support market growth
15.6.2.2 Saudi Arabia
15.6.2.2.1 Vision 2030 investments accelerate biotechnology and AI-enabled protein engineering
15.6.2.3 UAE
15.6.2.3.1 Healthcare innovation and biotechnology initiatives support market growth
15.6.2.4 Other GCC countries
15.6.3 SOUTH AFRICA
15.6.3.1 Expanding biotechnology and research capabilities support market growth
15.6.4 REST OF MIDDLE EAST & AFRICA

16.1 OVERVIEW
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS INAI IN PROTEIN ENGINEERING MARKET
16.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
16.4 MARKET SHARE ANALYSIS, 2025
16.5 BRAND COMPARISON
16.6 VALUATION & FINANCIAL METRICS
16.6.1 FINANCIAL METRICS
16.6.2 COMPANY VALUATION
16.7 COMPANY EVALUATION MATRIX, KEY PLAYERS (2025)
16.7.1 STARS
16.7.2 EMERGING LEADERS
16.7.3 PERVASIVE PLAYERS
16.7.4 PARTICIPANTS
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1 Company footprint
16.7.5.2 Region footprint
16.7.5.3 Offering footprint
16.7.5.4 Application footprint
16.7.5.5 AI tool footprint
16.7.5.6 End user footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1 PROGRESSIVE COMPANIES
16.8.2 RESPONSIVE COMPANIES
16.8.3 DYNAMIC COMPANIES
16.8.4 STARTING BLOCKS
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.8.5.1 Detailed list of key startups/SMEs
16.8.5.2 Competitive benchmarking of startups/SMEs
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
16.9.2 DEALS

17.1 KEY PLAYERS
17.1.1 SCHRÖDINGER, INC.
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Product enhancements
17.1.1.3.2 Deals
17.1.1.4 Analyst's view
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 XTALPI
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Deals
17.1.2.4 Analyst's view
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 DASSAULT SYSTÈMES
17.1.3.1 Business overview
17.1.3.2 Products Offered
17.1.3.3 Recent developments
17.1.3.3.1 Product launches/enhancements
17.1.3.3.2 Deals
17.1.3.4 Analyst's view
17.1.3.4.1 Key strengths
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 NVIDIA CORPORATION
17.1.4.1 Business overview
17.1.4.2 Products/Solutions offered
17.1.4.3 Recent developments
17.1.4.3.1 Product launches/enhancements
17.1.4.3.2 Deals
17.1.4.4 Analyst's view
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses and competitive threats
17.1.5 GENERATE:BIOMEDICINES
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.5.3 Recent developments
17.1.5.3.1 Product enhancements
17.1.5.3.2 Deals
17.1.5.4 Analyst's view
17.1.5.4.1 Key strengths
17.1.5.4.2 Strategic choices
17.1.5.4.3 Weaknesses and competitive threats
17.1.6 ABSCI CORP.
17.1.6.1 Business overview
17.1.6.2 Products Offered
17.1.6.3 Recent developments
17.1.6.3.1 Deals
17.1.6.4 Analyst's view
17.1.6.4.1 Key strengths
17.1.6.4.2 Strategic choices
17.1.6.4.3 Weaknesses and competitive threats
17.1.7 INSILICO MEDICINE
17.1.7.1 Business overview
17.1.7.2 Products/Solutions offered
17.1.7.3 Recent developments
17.1.7.3.1 Product launches/enhancements
17.1.7.3.2 Deals
17.1.7.4 Analyst's view
17.1.7.4.1 Key strengths
17.1.7.4.2 Strategic choices
17.1.7.4.3 Weaknesses and competitive threats
17.1.8 CRADLE
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.8.3 Recent developments
17.1.8.3.1 Deals
17.1.8.3.2 Other developments
17.1.9 A-ALPHA BIO, INC.
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.9.3 Recent developments
17.1.9.3.1 Product launches
17.1.9.3.2 Deals
17.1.9.3.3 Other developments
17.1.10 ISOMORPHIC LABS
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.10.3 Recent developments
17.1.10.3.1 Deals
17.1.10.3.2 Other developments
17.1.11 CHAI DISCOVERY
17.1.11.1 Business overview
17.1.11.2 Products offered
17.1.11.3 Recent developments
17.1.11.3.1 Product launches and approvals
17.1.11.3.2 Deals
17.1.11.3.3 Other developments
17.1.12 EVOLUTIONARYSCALE (BIOHUB)
17.1.12.1 Business overview
17.1.12.2 Products offered
17.1.12.3 Recent developments
17.1.12.3.1 Product launches and approvals
17.1.12.3.2 Deals
17.1.12.3.3 Other developments
17.1.13 PROFLUENT
17.1.13.1 Business overview
17.1.13.2 Products offered
17.1.13.3 Recent developments
17.1.13.3.1 Deals
17.1.13.3.2 Other developments
17.1.14 BIGHAT BIO
17.1.14.1 Business overview
17.1.14.2 Products offered
17.1.14.3 Recent developments
17.1.14.3.1 Product launches
17.1.14.3.2 Deals
17.1.15 LATENT LABS
17.1.15.1 Business overview
17.1.15.2 Products offered
17.1.15.3 Recent developments
17.1.15.3.1 Product launches
17.1.15.3.2 Deals
17.1.15.3.3 Other developments
17.1.16 BASECAMP RESEARCH
17.1.16.1 Business overview
17.1.16.2 Products offered
17.1.16.3 Recent developments
17.1.16.3.1 Product launches
17.1.16.3.2 Deals
17.1.16.3.3 Other developments
17.1.17 NABLA BIO, INC.
17.1.17.1 Business overview
17.1.17.2 Products offered
17.1.17.3 Recent developments
17.1.17.3.1 Deals
17.1.17.3.2 Other developments
17.1.18 EVOZYNE
17.1.18.1 Business overview
17.1.18.2 Products offered
17.1.18.3 Recent developments
17.1.18.3.1 Deals
17.1.18.3.2 Other developments
17.1.19 LABGENIUS LIMITED
17.1.19.1 Business overview
17.1.19.2 Products offered
17.1.19.3 Recent developments
17.1.19.3.1 Deals
17.1.19.3.2 Other developments
17.2 OTHER PLAYERS
17.2.1 ARZEDA CORPORATION
17.2.2 MENTEN AI
17.2.3 PROTEINQURE
17.2.4 OUTPACE BIO
17.2.5 AI PROTEINS
17.2.6 MONODBIO
17.2.7 BIOMATTER INC.
17.2.8 DIFFUSE BIO

18.1 RESEARCH APPROACH
18.1.1 SECONDARY RESEARCH
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY RESEARCH
18.1.2.1 Primary sources
18.1.2.2 Key data from primary sources
18.1.2.3 Breakdown of primaries
18.1.2.4 Insights from primary experts
18.2 RESEARCH METHODOLOGY DESIGN
18.3 MARKET SIZE ESTIMATION
18.4 MARKET BREAKDOWN DATA TRIANGULATION
18.5 MARKET SHARE ESTIMATION
18.6 STUDY ASSUMPTIONS
18.7 RESEARCH LIMITATIONS
18.7.1 METHODOLOGY-RELATED LIMITATIONS
18.8 RISK ASSESSMENT

19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS

TABLE 1 USD EXCHANGE RATES
TABLE 2 AI IN PROTEIN ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 AI IN PROTEIN ENGINEERING MARKET: ROLE IN ECOSYSTEM
TABLE 4 INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,BY OFFERING (2025)
TABLE 5 INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET, BY REGION (2025)
TABLE 6 AI IN PROTEIN ENGINEERING MARKET: KEY CONFERENCES, 2026-2027
TABLE 7 CASE 1: AI-GUIDED ENZYME OPTIMIZATION USING HISTORICALEXPERIMENTAL DATA
TABLE 8 CASE 2: AI-GENERATED PROTEIN DESIGN FOR PRECISION GENE EDITING
TABLE 9 CASE 3: COMPUTATIONAL PROTEIN DESIGN FOR AI-DESIGNEDPEPTIDE THERAPEUTIC
TABLE 10 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 11 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN PROTEIN ENGINEERING MARKET
TABLE 12 AI IN PROTEIN ENGINEERING MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENTAGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 REGULATORY SCENARIO OF NORTH AMERICA
TABLE 19 REGULATORY SCENARIO OF EUROPE
TABLE 20 REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 21 REGULATORY SCENARIO OF LATIN AMERICA
TABLE 22 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OFTOP THREE END USERS (%)
TABLE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 25 UNMET NEEDS IN AI IN PROTEIN ENGINEERING MARKET
TABLE 26 END USER EXPECTATIONS IN AI IN PROTEIN ENGINEERING MARKET
TABLE 27 AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 28 AI IN PROTEIN ENGINEERING MARKET, FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 29 AI IN PROTEIN ENGINEERING MARKET, FOR SOFTWARE/PLATFORMS,BY REGION, 2024-2031 (USD MILLION)
TABLE 30 AI IN PROTEIN ENGINEERING MARKET, FOR NICHE POINT SOLUTIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 31 AI IN PROTEIN ENGINEERING MARKET, FOR END-TO-END SOLUTIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 32 AI IN PROTEIN ENGINEERING MARKET, FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 33 AI IN PROTEIN ENGINEERING MARKET, FOR SERVICES, BY REGION,2024-2031 (USD MILLION)
TABLE 34 AI IN PROTEIN ENGINEERING MARKET, FOR CONSULTING & ADVISORY SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 35 AI IN PROTEIN ENGINEERING MARKET, FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 36 AI IN PROTEIN ENGINEERING MARKET, FOR TRAINING & SUPPORT SERVICES,BY REGION, 2024-2031 (USD MILLION)
TABLE 37 AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024-2031 (USD MILLION)
TABLE 38 AI IN PROTEIN ENGINEERING MARKET FOR MACHINE LEARNING & DEEP LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN LANGUAGE MODELS,BY REGION, 2024-2031 (USD MILLION)
TABLE 40 AI IN PROTEIN ENGINEERING MARKET FOR GENERATIVE AI, BY REGION,2024-2031 (USD MILLION)
TABLE 41 AI IN PROTEIN ENGINEERING MARKET FOR STRUCTURE-BASED AI,BY REGION, 2024-2031 (USD MILLION)
TABLE 42 AI IN PROTEIN ENGINEERING MARKET FOR OTHER TOOLS, BY REGION,2024-2031 (USD MILLION)
TABLE 43 AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 44 AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 45 AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS,BY REGION, 2024-2031 (USD MILLION)
TABLE 46 AI IN PROTEIN ENGINEERING MARKET FOR THERAPEUTIC PROTEIN ENGINEERING, BY REGION, 2024-2031 (USD MILLION)
TABLE 47 AI IN PROTEIN ENGINEERING MARKET FOR MULTISPECIFIC & BISPECIFIC PROTEIN ENGINEERING, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 AI IN PROTEIN ENGINEERING MARKET FOR CYTOKINE & GROWTH FACTOR ENGINEERING, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN BINDER ENGINEERING,BY REGION, 2024-2031 (USD MILLION)
TABLE 50 AI IN PROTEIN ENGINEERING MARKET FOR OTHER NEXT-GENERATION BIOLOGICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 AI IN PROTEIN ENGINEERING MARKET FOR MOLECULAR GLUES, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 AI IN PROTEIN ENGINEERING MARKET FOR DATA GENERATION, BY REGION,2024-2031 (USD MILLION)
TABLE 53 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 54 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY, BY REGION, 2024-2031 (USD MILLION)
TABLE 56 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY AFFINITY OPTIMIZATION,BY REGION, 2024-2031 (USD MILLION)
TABLE 57 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY SPECIFICITY & CROSS-REACTIVITY OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 58 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DEVELOPABILITY OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 AI IN PROTEIN ENGINEERING MARKET FOR BISPECIFIC & MULTISPECIFIC ANTIBODY ENGINEERING, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 AI IN PROTEIN ENGINEERING MARKET FOR OTHER ANTIBODY ENGINEERING,BY REGION, 2024-2031 (USD MILLION)
TABLE 61 AI IN PROTEIN ENGINEERING MARKET FOR ENZYME ENGINEERING,BY REGION, 2024-2031 (USD MILLION)
TABLE 62 AI IN PROTEIN ENGINEERING MARKET FOR DE NOVO PROTEIN DESIGN,BY REGION, 2024-2031 (USD MILLION)
TABLE 63 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN STABILITY & DEVELOPABILITY OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 AI IN PROTEIN ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 65 AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 66 AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODIES, BY REGION,2024-2031 (USD MILLION)
TABLE 67 AI IN PROTEIN ENGINEERING MARKET FOR ENZYMES, BY REGION,2024-2031 (USD MILLION)
TABLE 68 AI IN PROTEIN ENGINEERING MARKET FOR CYTOKINES & GROWTH FACTORS,BY REGION, 2024-2031 (USD MILLION)
TABLE 69 AI IN PROTEIN ENGINEERING MARKET FOR PEPTIDES, BY REGION,2024-2031 (USD MILLION)
TABLE 70 AI IN PROTEIN ENGINEERING MARKET FOR FUSION PROTEINS, BY REGION,2024-2031 (USD MILLION)
TABLE 71 AI IN PROTEIN ENGINEERING MARKET FOR MINIPROTEIN, BY REGION,2024-2031 (USD MILLION)
TABLE 72 AI IN PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS, BY REGION,2024-2031 (USD MILLION)
TABLE 73 AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 74 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN DISCOVERY, BY REGION, 2024-2031 (USD MILLION)
TABLE 75 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN DESIGN, BY REGION,2024-2031 (USD MILLION)
TABLE 76 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN OPTIMIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN CHARACTERIZATION,BY REGION, 2024-2031 (USD MILLION)
TABLE 78 AI IN PROTEIN ENGINEERING MARKET FOR EXPERIMENTAL VALIDATION,BY REGION, 2024-2031 (USD MILLION)
TABLE 79 AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 80 AI IN PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 AI IN PROTEIN ENGINEERING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 AI IN PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 AI IN PROTEIN ENGINEERING MARKET FOR INDUSTRIAL BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 AI IN PROTEIN ENGINEERING MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 85 AI IN PROTEIN ENGINEERING MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 NORTH AMERICA AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 87 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 88 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 89 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 90 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 91 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 92 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 93 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 94 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 95 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 96 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 97 US: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 98 US: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 99 US: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 100 US: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 101 US: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 102 US: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 103 US: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 US: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 105 US: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 106 US: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 107 CANADA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 108 CANADA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 109 CANADA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 110 CANADA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 111 CANADA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 112 CANADA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 113 CANADA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 114 CANADA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 115 CANADA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 116 CANADA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 117 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 118 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 119 EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 120 EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 122 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 123 EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 124 EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 125 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 126 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 127 EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 128 GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 129 GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 130 GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 132 GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 133 GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 134 GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 136 GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 137 GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 138 FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 139 FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 140 FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 141 FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 142 FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 143 FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 144 FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 146 FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 147 FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 148 UK: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 149 UK: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 150 UK: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 151 UK: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 152 UK: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 153 UK: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 154 UK: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 UK: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 156 UK: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 157 UK: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 158 ITALY: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 159 ITALY: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 160 ITALY: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 161 ITALY: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 162 ITALY: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 163 ITALY: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 ITALY: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 165 ITALY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 166 ITALY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 167 ITALY: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 168 SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 169 SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 171 SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 172 SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 173 SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 174 SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 175 SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 176 SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 177 SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 178 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 179 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 180 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 182 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 183 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 184 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 186 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 187 REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 188 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 189 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 190 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 191 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 193 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 194 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 197 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 198 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 199 CHINA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 200 CHINA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 CHINA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 202 CHINA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 203 CHINA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 204 CHINA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 CHINA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 CHINA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 207 CHINA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 208 CHINA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 209 JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 210 JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 212 JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 213 JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 214 JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 215 JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 217 JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 218 JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 219 INDIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 220 INDIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 221 INDIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 222 INDIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 223 INDIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 224 INDIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 INDIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 226 INDIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 227 INDIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 228 INDIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 229 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 230 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 233 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 234 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 235 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 236 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 237 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 238 AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 239 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 240 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 242 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 243 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 244 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 245 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 247 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 248 SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 249 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 250 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET,BY AI TOOL, 2024-2031 (USD MILLION)
TABLE 253 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET,BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 258 REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 259 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 260 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 261 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 262 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 264 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 265 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 268 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 269 LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 270 BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 271 BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 272 BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 273 BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 274 BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 275 BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 277 BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 278 BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 279 BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 280 MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 281 MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 283 MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 284 MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 285 MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 288 MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 289 MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 290 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 291 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 292 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024-2031 (USD MILLION)
TABLE 294 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 295 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 296 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 298 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 299 REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 300 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 301 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 302 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 303 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024-2031 (USD MILLION)
TABLE 305 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 306 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 307 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 308 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 309 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 310 MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY END USER, 2024-2031 (USD MILLION)
TABLE 311 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 312 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 313 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 316 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 317 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 318 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 319 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 320 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 321 GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 322 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 323 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 325 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 326 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 327 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 328 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 329 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 330 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 331 SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 332 UAE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 333 UAE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 UAE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 335 UAE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 336 UAE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 337 UAE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 338 UAE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 339 UAE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 340 UAE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 341 UAE: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 342 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 343 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024-2031 (USD MILLION)
TABLE 346 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 347 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 348 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 350 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 351 OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 352 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 353 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 354 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL,2024-2031 (USD MILLION)
TABLE 356 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 357 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE,2024-2031 (USD MILLION)
TABLE 360 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 361 SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 362 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 363 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKETFOR SOFTWARE/PLATFORMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 364 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKETFOR SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 365 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY AI TOOL, 2024-2031 (USD MILLION)
TABLE 366 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 367 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKETFOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 369 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY PROTEIN TYPE, 2024-2031 (USD MILLION)
TABLE 370 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY PROTEIN ENGINEERING PROCESS, 2024-2031 (USD MILLION)
TABLE 371 REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET,BY END USER, 2024-2031 (USD MILLION)
TABLE 372 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN PROTEIN ENGINEERING MARKET, JANUARY 2023-SEPTEMBER 2026
TABLE 373 THE AI IN PROTEIN ENGINEERING MARKET: DEGREE OF COMPETITION
TABLE 374 AI IN PROTEIN ENGINEERING MARKET: REGION FOOTPRINT
TABLE 375 AI IN PROTEIN ENGINEERING MARKET: OFFERING FOOTPRINT
TABLE 376 AI IN PROTEIN ENGINEERING MARKET: APPLICATION FOOTPRINT
TABLE 377 AI IN PROTEIN ENGINEERING MARKET: AI TOOL FOOTPRINT
TABLE 378 AI IN PROTEIN ENGINEERING MARKET: END USER FOOTPRINT
TABLE 379 AI IN PROTEIN ENGINEERING MARKET: DETAILED LIST OFKEY STARTUP/SME PLAYERS
TABLE 380 AI IN PROTEIN ENGINEERING MARKET: COMPETITIVE BENCHMARKINGOF KEY EMERGING PLAYERS/STARTUPS, BY REGION
TABLE 381 AI IN PROTEIN ENGINEERING MARKET: COMPETITIVE BENCHMARKINGOF KEY EMERGING PLAYERS/STARTUPS, BY OFFERING
TABLE 382 AI IN PROTEIN ENGINEERING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023-SEPTEMBER 2026
TABLE 383 AI IN PROTEIN ENGINEERING MARKET: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 384 SCHRÖDINGER, INC.: COMPANY OVERVIEW
TABLE 385 SCHRÖDINGER, INC.: PRODUCTS OFFERED
TABLE 386 SCHRÖDINGER, INC.: PRODUCT ENHANCEMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 387 SCHRÖDINGER, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 388 XTALPI: COMPANY OVERVIEW
TABLE 389 XTALPI: PRODUCTS OFFERED
TABLE 390 XTALPI: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 391 DASSAULT SYSTÈMES: COMPANY OVERVIEW
TABLE 392 DASSAULT SYSTÈMES: PRODUCTS OFFERED
TABLE 393 DASSAULT SYSTÈMES: PRODUCT LAUNCHES/ENHANCEMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 394 DASSAULT SYSTÈMES: DEALS, JANUARY 2023- SEPTEMBER 2026
TABLE 395 NVIDIA CORPORATION: COMPANY OVERVIEW
TABLE 396 NVIDIA CORPORATION: PRODUCTS /SOLUTIONS OFFERED
TABLE 397 NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 398 NVIDIA CORPORATION: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 399 GENERATE:BIOMEDICINES: COMPANY OVERVIEW
TABLE 400 GENERATE:BIOMEDICINES: PRODUCTS OFFERED
TABLE 401 GENERATE:BIOMEDICINES: PRODUCT ENHANCEMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 402 GENERATE:BIOMEDICINES: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 403 ABSCI CORP.: COMPANY OVERVIEW
TABLE 404 ABSCI CORP.: PRODUCTS OFFERED
TABLE 405 ABSCI CORP.: DEALS, JANUARY 2023- SEPTEMBER 2026
TABLE 406 INSILICO MEDICINE: COMPANY OVERVIEW
TABLE 407 INSILICO MEDICINE: PRODUCTS /SOLUTIONS OFFERED
TABLE 408 INSILICO MEDICINE: PRODUCT LAUNCHES/ENHANCEMENT,JANUARY 2023-SEPTEMBER 2026
TABLE 409 INSILICO MEDICINE: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 410 CRADLE: COMPANY OVERVIEW
TABLE 411 CRADLE: PRODUCTS OFFERED
TABLE 412 CRADLE: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 413 CRADLE: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 414 A-ALPHA BIO, INC.: COMPANY OVERVIEW
TABLE 415 A-ALPHA BIO, INC.: PRODUCTS OFFERED
TABLE 416 A-ALPHA BIO, INC.: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 417 A-ALPHA BIO, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 418 A-ALPHA BIO, INC.: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 419 ISOMORPHIC LABS: COMPANY OVERVIEW
TABLE 420 ISOMORPHIC LABS: PRODUCTS OFFERED
TABLE 421 ISOMORPHIC LABS: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 422 ISOMORPHIC LABS: OTHER DEVELOPMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 423 CHAI DISCOVERY: COMPANY OVERVIEW
TABLE 424 CHAI DISCOVERY: PRODUCTS OFFERED
TABLE 425 CHAI DISCOVERY: PRODUCT LAUNCHES AND APPROVALS,JANUARY 2023-SEPTEMBER 2026
TABLE 426 CHAI DISCOVERY: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 427 CHAI DISCOVERY: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 428 EVOLUTIONARYSCALE (BIOHUB): COMPANY OVERVIEW
TABLE 429 EVOLUTIONARYSCALE (BIOHUB): PRODUCTS OFFERED
TABLE 430 EVOLUTIONARYSCALE (BIOHUB): PRODUCT LAUNCHES AND APPROVALS,JANUARY 2023-SEPTEMBER 2026
TABLE 431 EVOLUTIONARYSCALE (BIOHUB): DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 432 EVOLUTIONARYSCALE (BIOHUB): OTHER DEVELOPMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 433 PROFLUENT: COMPANY OVERVIEW
TABLE 434 PROFLUENT: PRODUCTS OFFERED
TABLE 435 PROFLUENT: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 436 PROFLUENT: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 437 BIGHAT BIO: COMPANY OVERVIEW
TABLE 438 BIGHAT BIO: PRODUCTS OFFERED
TABLE 439 BIGHAT BIO: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 440 BIGHAT BIO: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 441 LATENT LABS: COMPANY OVERVIEW
TABLE 442 LATENT LABS: PRODUCTS OFFERED
TABLE 443 LATENT LABS: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 444 LATENT LABS: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 445 LATENT LABS: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 446 BASECAMP RESEARCH: COMPANY OVERVIEW
TABLE 447 BASECAMP RESEARCH: PRODUCTS OFFERED
TABLE 448 BASECAMP RESEARCH: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 449 BASECAMP RESEARCH: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 450 BASECAMP RESEARCH: OTHER DEVELOPMENTS,JANUARY 2023-SEPTEMBER 2026
TABLE 451 NABLA BIO, INC.: COMPANY OVERVIEW
TABLE 452 NABLA BIO, INC.: PRODUCTS OFFERED
TABLE 453 NABLA BIO, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 454 NABLA BIO, INC.: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 455 EVOZYNE: COMPANY OVERVIEW
TABLE 456 EVOZYNE: PRODUCTS OFFERED
TABLE 457 EVOZYNE: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 458 EVOZYNE: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 459 LABGENIUS LIMITED: COMPANY OVERVIEW
TABLE 460 LABGENIUS LIMITED: PRODUCTS OFFERED
TABLE 461 LABGENIUS LIMITED: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 462 LABGENIUS LIMITED: OTHER DEVELOPMENTS, JANUARY 2023-SEPTEMBER 2026
TABLE 463 ARZEDA CORPORATION: COMPANY OVERVIEW
TABLE 464 MENTEN AI: COMPANY OVERVIEW
TABLE 465 PROTEINQURE: COMPANY OVERVIEW
TABLE 466 OUTPACE BIO: COMPANY OVERVIEW
TABLE 467 AI PROTEINS: COMPANY OVERVIEW
TABLE 468 MONODBIO: COMPANY OVERVIEW
TABLE 469 BIOMATTER INC.: COMPANY OVERVIEW
TABLE 470 DIFFUSE BIO: COMPANY OVERVIEW
TABLE 471 RISK ASSESSMENT: AI IN PROTEIN ENGINEERING MARKET

FIGURE 1 AI IN PROTEIN ENGINEERING MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL AI IN PROTEIN ENGINEERING MARKET, 2024-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN PROTEIN ENGINEERING MARKET, 2023-2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF AI IN PROTEIN ENGINEERING MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN AI IN PROTEIN ENGINEERING MARKET, 2026-2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN AI IN PROTEIN ENGINEERING MARKET DURING FORECAST PERIOD
FIGURE 8 INCREASING R&D INVESTMENTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE GROWTH IN AI IN PROTEIN ENGINEERING MARKET
FIGURE 9 SOFTWARE/PLATFORMS HELD MAJOR SHARE IN NORTH AMERICA IN 2025
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11 AI IN PROTEIN ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 12 AI IN PROTEIN ENGINEERING MARKET: VALUE CHAIN ANALYSIS
FIGURE 13 AI IN PROTEIN ENGINEERING MARKET: ECOSYSTEM ANALYSIS
FIGURE 14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 16 PATENT PUBLICATION TRENDS IN AI IN PROTEIN ENGINEERING MARKET,2015-2026
FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS FOR AI INPROTEIN ENGINEERING MARKET
FIGURE 18 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN PROTEIN ENGINEERING MARKET (JANUARY 2015 TO JUNE 2026)
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 20 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 21 NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET SNAPSHOT
FIGURE 22 ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET SNAPSHOT
FIGURE 23 AI IN PROTEIN ENGINEERING MARKET: REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 24 AI IN PROTEIN ENGINEERING MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 25 AI IN PROTEIN ENGINEERING MARKET: BRAND COMPARATIVE ANALYSIS
FIGURE 26 EV/EBITDA OF KEY VENDORS
FIGURE 27 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCKBETA OF KEY VENDORS
FIGURE 28 AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX (2025)
FIGURE 29 AI IN PROTEIN ENGINEERING MARKET: COMPANY FOOTPRINT
FIGURE 30 AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31 SCHRÖDINGER, INC.: COMPANY SNAPSHOT (2025)
FIGURE 32 XTALPI: COMPANY SNAPSHOT (2025)
FIGURE 33 DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2025)
FIGURE 34 NVIDIA CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 35 ABSCI CORP.: COMPANY SNAPSHOT (2025)
FIGURE 36 INSILICO MEDICINE: COMPANY SNAPSHOT (2025)
FIGURE 37 RESEARCH DESIGN
FIGURE 38 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,DESIGNATION, AND REGION
FIGURE 39 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 40 BOTTOM-UP APPROACH
FIGURE 41 TOP-DOWN APPROACH
FIGURE 42 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AI IN PROTEIN ENGINEERING INDUSTRY
FIGURE 43 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 44 DATA TRIANGULATION METHODOLOGY